The Challenges of Managing Malignant Pancreatic Tumors in a Gabonese Hospital Setting
- 1 Department of Hepatology and Gastroenterology, University Hospital Center of Libreville, Libreville, Gabon
- 2 Department of Hepatology and Gastroenterology, University Hospital Center of Libreville, Libreville, Gabon
- 3 Department of Hepatology and Gastroenterology, University Hospital Center of Libreville, Libreville, Gabon
- 4 Department of Hepatology and Gastroenterology, University Hospital Center of Libreville, Libreville, Gabon
- 5 Department of Hepatology and Gastroenterology, University Hospital Center of Libreville, Libreville, Gabon
- 6 Department of Hepatology and Gastroenterology, University Hospital Center of Libreville, Libreville, Gabon
- 7 Department of Hepatology and Gastroenterology, University Hospital Center of Libreville, Libreville, Gabon
- 8 Department of Hepatology and Gastroenterology, University Hospital Center of Libreville, Libreville, Gabon
- 9 Department of Hepatology and Gastroenterology, University Hospital Center of Libreville, Libreville, Gabon
Abstract
Introduction: Pancreatic cancer is one of the most lethal emerging gastrointestinal malignancies. Its management in low-resource settings remains a major challenge. The study aimed to describe the epidemiological, diagnostic, and prognostic characteristics of pancreatic cancer at the University Hospital Center (CHU). Methods: We conducted a retrospective, descriptive cross-sectional study in the Hepatogastroenterology Department of the Libreville University Hospital Center from January 1, 2021, to December 31, 2023. A presumptive diagnosis of pancreatic cancer was established based on Computed Tomography (CT) and/or Magnetic Resonance Imaging (MRI) findings. Sociodemographic, diagnostic, and outcome data were collected and analyzed using Epi Info software version 7.6.2.0. Results: The hospital frequency of pancreatic cancer was 1.8% of all hospitalizations and 21.43% of pancreatic diseases. The sex ratio was 1.06, with a mean age of 59 ± 8.87 years. Excessive alcohol consumption (45.45%), diabetes (24.24%), and smoking (21.21%) were the most frequently reported associated exposures. The main clinical manifestations included abdominal pain (93.93%), weight loss (87.87%), asthenia (84.84%), jaundice (69.7%), and a palpable epigastric mass (42.42%). Tumors were predominantly located in the head and body of the pancreas (75.76%), with a mean size of 3.8 cm (±1.5 cm). The mortality rate was 36.36%. Conclusion: Pancreatic cancer was relatively frequent among pancreatic diseases but remained infrequent at the hospital level. It was predominantly diagnosed at an advanced stage, resulting in a poor prognosis. Alcohol consumption and chronic smoking appeared to be the most common associated exposures.
- Hu, J.X., Zhao, C.F., Chen, W.B., Liu, Q.C., Li, Q.W., Lin, Y.Y., et al . (2021) Pancreatic Cancer: A Review of Epidemiology, Trend, and Risk Factors. World Journal of Gastroenterology , 27, 4298-4321. https://doi.org/10.3748/wjg.v27.i27.4298
- Bray, F., Laversanne, M., Sung, H., Ferlay, J., Siegel, R.L., Soerjomataram, I., et al . (2024) Global Cancer Statistics 2022: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA : A Cancer Journal for Clinicians , 74, 229-263. https://doi.org/10.3322/caac.21834
- Maganga Moussavou, I.F., Itoudi Bignoumba, P.E., Saïbou, M., Mbounja, M., Eyi Nguema, A.G., Nsegue Mezui, A., et al . (2021) Overview of Digestive Cancers in the Hepatogastroenterology Department of the Libreville University Hospital. Bulletin Médical d ’ Owendo , 19, 54-57.
- Molua, A.A., Matondo, E.M.M., Lelo, M.T., Mukaya, J.T., Mbongo, A.T. and Mazoba, T.K. (2022) Scanographic Profile Tumors from 3 Radiology Division in Kinshasa: Retrospective Serial Cases. Annales Africaines de Medecine , 15, e4802-e4809. https://doi.org/10.4314/aamed.v15i4.6
- Sellam, F., Harir, N., Khaled, M.B., Mrabent, M.N., Salah, R., Diaf, M., et al . (2015) Aspects épidémiologiques et histopronostiques du cancer pancréatique au niveau de l’Ouest Algérien à propos de 160 cas. Journal Africain d ’ Hépato - Gastroentérologie , 9, 76-79. https://doi.org/10.1007/s12157-015-0592-x
- Singhi, A.D., Koay, E.J., Chari, S.T. and Maitra, A. (2019) Early Detection of Pancreatic Cancer: Opportunities and Challenges. Gastroenterology , 156, 2024-2040. https://doi.org/10.1053/j.gastro.2019.01.259
- Hosoda, W., Sasaki, E., Murakami, Y., Yamao, K., Shimizu, Y. and Yatabe, Y. (2015) GNAS Mutation Is a Frequent Event in Pancreatic Intraductal Papillary Mucinous Neoplasms and Associated Adenocarcinomas. Virchows Archiv , 466, 665-674. https://doi.org/10.1007/s00428-015-1751-6
- de Mestier, L., Védie, A.L., Salfati, D., Rebours, V. and Hammel, P. (2017) Pancreatic Cancer: Causes, Genetic Forms and Screening. Hépato - Gastro & Oncologie Digestive , 24, 7-17.
- Singhi, A.D. and Wood, L.D. (2021) Early Detection of Pancreatic Cancer Using DNA-Based Molecular Approaches. Nature Reviews Gastroenterology & Hepatology , 18, 457-468. https://doi.org/10.1038/s41575-021-00470-0
- Vasseur, R., Skrypek, N., Duchêne, B., Renaud, F., Martínez-Maqueda, D., Vincent, A., et al . (2015) The Mucin MUC4 Is a Transcriptional and Post-Transcriptional Target of K-Ras Oncogene in Pancreatic Cancer. Implication of MAPK/AP-1, NF-κB and RALB Signaling Pathways. Biochimica et Biophysica Acta ( BBA )— Gene Regulatory Mechanisms , 1849, 1375-1384. https://doi.org/10.1016/j.bbagrm.2015.10.014